168 related articles for article (PubMed ID: 32244421)
1. Modeling of the HIV-1 Life Cycle in Productively Infected Cells to Predict Novel Therapeutic Targets.
Shcherbatova O; Grebennikov D; Sazonov I; Meyerhans A; Bocharov G
Pathogens; 2020 Mar; 9(4):. PubMed ID: 32244421
[TBL] [Abstract][Full Text] [Related]
2. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
[TBL] [Abstract][Full Text] [Related]
3. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
4. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
Guedj J; Neumann AU
J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of viral RNA synthesis following cell-to-cell transmission of human immunodeficiency virus type 1.
Davis AJ; Li P; Burrell CJ
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1897-906. PubMed ID: 9266985
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectors.
Kim JH; McLinden RJ; Mosca JD; Vahey MT; Greene WC; Redfield RR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):343-51. PubMed ID: 8673542
[TBL] [Abstract][Full Text] [Related]
7. Robust growth of human immunodeficiency virus type 1 (HIV-1).
Kim H; Yin J
Biophys J; 2005 Oct; 89(4):2210-21. PubMed ID: 16055539
[TBL] [Abstract][Full Text] [Related]
8. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
Fang J; Acheampong E; Dave R; Wang F; Mukhtar M; Pomerantz RJ
Virology; 2005 Jun; 336(2):299-307. PubMed ID: 15892970
[TBL] [Abstract][Full Text] [Related]
9. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells.
Zhu M; Duan L; Pomerantz RJ
AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1093-101. PubMed ID: 8844014
[TBL] [Abstract][Full Text] [Related]
10. A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.
Lin MH; Sivakumaran H; Jones A; Li D; Harper C; Wei T; Jin H; Rustanti L; Meunier FA; Spann K; Harrich D
Retrovirology; 2014 Dec; 11():121. PubMed ID: 25496916
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 regulatory proteins: targets for novel drug development.
Ptak RG
Expert Opin Investig Drugs; 2002 Aug; 11(8):1099-115. PubMed ID: 12150704
[TBL] [Abstract][Full Text] [Related]
12. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines.
Ranki A; Lagerstedt A; Ovod V; Aavik E; Krohn KJ
Arch Virol; 1994; 139(3-4):365-78. PubMed ID: 7832642
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of an HIV Model with Multiple Infection Stages and Treatment with Different Drug Classes.
Wang X; Song X; Tang S; Rong L
Bull Math Biol; 2016 Feb; 78(2):322-49. PubMed ID: 26842389
[TBL] [Abstract][Full Text] [Related]
14. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev.
Gorry PR; Howard JL; Churchill MJ; Anderson JL; Cunningham A; Adrian D; McPhee DA; Purcell DF
J Virol; 1999 Jan; 73(1):352-61. PubMed ID: 9847339
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles.
Arizala JAC; Takahashi M; Burnett JC; Ouellet DL; Li H; Rossi JJ
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):961-981. PubMed ID: 29804468
[TBL] [Abstract][Full Text] [Related]
16. Simple mathematical models do not accurately predict early SIV dynamics.
Noecker C; Schaefer K; Zaccheo K; Yang Y; Day J; Ganusov VV
Viruses; 2015 Mar; 7(3):1189-217. PubMed ID: 25781919
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
[TBL] [Abstract][Full Text] [Related]
18. Subcellular Localization of HIV-1
Becker JT; Sherer NM
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
[TBL] [Abstract][Full Text] [Related]
19. New therapeutic approaches targeted at the late stages of the HIV-1 replication cycle.
Jiang Y; Liu X; De Clercq E
Curr Med Chem; 2011; 18(1):16-28. PubMed ID: 21110817
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
